Schizophrenia and neural tube defects: Comparisons from an epidemiological perspective

Schizophrenia Bulletin

Volumn 33, Issue 4, 2007, Pages 853-858

  Zammit, Stanley ^a,b   Lewis, Sarah ^a   Gunnell, David ^a   Smith, George Davey ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

5,10 methylenetetrahydrofolate reductase; Epidemiology; Folic acid; Micronutrients; Neural tube defects; Schizophrenia

Indexed keywords

CONFERENCE PAPER; DIET SUPPLEMENTATION; FETAL MALNUTRITION; GEOGRAPHIC DISTRIBUTION; HIGH RISK POPULATION; HUMAN; HYPERHOMOCYSTEINEMIA; MATERNAL DIABETES MELLITUS; NEURAL TUBE DEFECT; PARITY; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA; SEASONAL VARIATION; VITAMIN SUPPLEMENTATION;

BIRTH INTERVALS; FEMALE; FETAL DEVELOPMENT; FOLIC ACID DEFICIENCY; GEOGRAPHY; HOMOCYSTEINE; HUMANS; INCIDENCE; METHYLENETETRAHYDROFOLATE DEHYDROGENASE (NAD+); NEURAL TUBE DEFECTS; NUTRITION DISORDERS; PHENOTYPE; PREGNANCY; RISK FACTORS; SCHIZOPHRENIA; SEASONS; STARVATION;

EID: 34547683246     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbl041     Document Type: Conference Paper

References (57)

1. McGrath J, Saha S, Welham J, El Saadi O, MacCauley C, Chant D. A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med. 2004;2:13.
2. Harrison PJ. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain. 1999;122(pt 4):593-624.
3. Marenco S, Weinberger DR. The neurodevelopmental hypothesis of schizophrenia: following a trail of evidence from cradle to grave. Dev Psychopathol. 2000;12:501-527.
4. Little J, Elwood M. Geographical variation. In: Elwood MJ, Little J, Elwood HJ, eds. Epidemiology and Control of Neural Tube Defects. Oxford, England: Oxford University Press; 1992.
5. Detrait ER, George TM, Etchevers HC, Gilbert JR, Vekemans M, Speer MC. Human neural tube defects: developmental biology, epidemiology, and genetics. Neurotoxicol Teratol. 2005;27:515-524.
6. Frey L, Hauser WA. Epidemiology of neural tube defects. Epilepsia. 2003;44(suppl 3):4-13.
7. Mitchell LE. Epidemiology of neural tube defects. Am J Med Genet C Semin Med Genet. 2005;135:88-94.
8. MRC. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet. 1991;338:131-137.
9. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992;327:1832-1835.
10. Juriloff DM, Harris MJ. Mouse models for neural tube closure defects. Hum Mol Genet. 2000;9:993-1000.
11. Little J, Elwood H. Socio-economic status and occupation. In: Elwood MJ, Little J, Elwood HJ, eds. Epidemiology and Control of Neural Tube Defects. Oxford, England: Oxford University Press; 1992.
12. Elwood M, Little J. Secular trends. In: Elwood MJ, Little J, Elwood HJ, eds. Epidemiology and Control of Neural Tube Defects. Oxford, England: Oxford University Press; 1992.
13. Stein Z, Susser M, Saenger G, Marolla F. Famine and Human Development: The Dutch Hunger Winter of 1944-45. New York, NY: Oxford University Press; 1975.
14. Little J, Elwood M. Seasonal variation. In: Elwood MJ, Little J, Elwood HJ, eds. Epidemiology and Control of Neural Tube Defects. Oxford, England: Oxford University Press; 1992.
15. Elwood M, Elwood H, Little J. Diet. In: Elwood MJ, Little J, Elwood HJ, eds. Epidemiology and Control of Neural Tube Defects. Oxford, England: Oxford University Press; 1992.
16. Susser E, Neugebauer R, Hoek HW, et al. Schizophrenia after prenatal famine. Further evidence. Arch Gen Psychiatry. 1996;53:25-31.
17. St Clair D, Xu M, Wang P, et al. Rates of adult schizophrenia following prenatal exposure to the Chinese famine of 1959-1961. JAMA. 2005;294:557-562.
18. Takei N, Lewis G, Sham PC, Murray RM. Age-period-cohort analysis of the incidence of schizophrenia in Scotland. Psychol Med. 1996;26:963-973.
19. Munk-Jorgensen P, Mortensen PB. Incidence and other aspects of the epidemiology of schizophrenia in Denmark, 1971-87. Br J Psychiatry. 1992;161:489-495.
20. Bresnahan M, Boydell J, Murray R, Susser E. Temporal variation in schizophrenia. In: Murray RM, Jones PB, Susser E, van Os J, Cannon M, eds. The Epidemiology of Schizophrenia. Cambridge, UK: Cambridge University Press; 2003.
21. Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G. Self-reported cannabis use as a risk factor for schizophrenia: further analysis of the 1969 Swedish conscript cohort. BMJ. 2002;325:1199-1201.
22. Sipos A, Rasmussen F, Harrison G, et al. Paternal age and schizophrenia: a population based cohort study. BMJ. 2004;329:1070.
23. Marzullo G, Fraser FC. Similar rhythms of seasonal conceptions in neural tube defects and schizophrenia: a hypothesis of oxidant stress and the photoperiod. Birth Defects Res Part A Clin Mol Teratol. 2005;73:1-5.
24. Torrey EF, Miller J, Rawlings R, Yolken RH. Seasonality of births in schizophrenia and bipolar disorder: a review of the literature. Schizophr Res. 1997;28:1-38.
25. Forssen KM, Jagerstad MI, Wigertz K, Witthoft CM. Folates and dairy products: a critical update. J Am Coll Nutr. 2000;19(suppl):100S-110S.
26. Jiang T, Christian P, Khatry SK, Wu L, West KP Jr. Micronutrient deficiencies in early pregnancy are common, concurrent, and vary by season among rural Nepali pregnant women. J Nutr. 2005;135:1106-1112.
27. Bates CJ, Prentice AM, Paul AA. Seasonal variations in vitamins A, C, riboflavin and folate intakes and status of pregnant and lactating women in a rural Gambian community: some possible implications. Eur J Clin Nutr. 1994;48:660-668.
28. Bruinse HW, van den Berg H. Changes of some vitamin levels during and after normal pregnancy. Eur J Obstet Gynecol Reprod Biol. 1995;61:31-37.
29. Todoroff K, Shaw GM. Prior spontaneous abortion, prior elective termination, interpregnancy interval, and risk of neural tube defects. Am J Epidemiol. 2000;151:505-511.
30. Wild J, Read AP, Sheppard S, et al. Recurrent neural tube defects, risk factors and vitamins. Arch Dis Child. 1986;61:440-444.
31. Westergaard T, Mortensen PB, Pedersen CB, Wohlfahrt J, Melbye M. Exposure to prenatal and childhood infections and the risk of schizophrenia: suggestions from a study of sibship characteristics and influenza prevalence. Arch Gen Psychiatry. 1999;56:993-998.
32. Smits L, Pedersen C, Mortensen P, van Os J. Association between short birth intervals and schizophrenia in the offspring. Schizophr Res. 2004;70:49-56.
33. Lynberg MC, Khoury MJ, Lu X, Cocian T. Maternal flu, fever, and the risk of neural tube defects: a population-based case-control study. Am J Epidemiol. 1994;140:244-255.
34. Moretti ME, Bar-Oz B, Fried S, Koren G. Maternal hyperthermia and the risk for neural tube defects in offspring: systematic review and meta-analysis. Epidemiology. 2005;16:216-219.
35. Cannon M, Kendell R, Susser E, Jones PB. Prenatal and perinatal risk factors for schizophrenia. In: Murray RM, Jones PB, Susser E, van Os J, Cannon M, eds. The Epidemiology of Schizophrenia. Cambridge, UK: Cambridge University Press; 2003.
36. Brown AS, Begg MD, Gravenstein S, et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry. 2004;61:774-780.
37. Brown AS, Hooton J, Schaefer CA, et al. Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am J Psychiatry. 2004;161:889-895.
38. Meyer U, Feldon J, Schedlowski M, Yee BK. Immunological stress at the maternal-foetal interface: a link between neurodevelopment and adult psychopathology. Brain Behav Immun. 2006;20(4):378-388.
39. Klaning U, Mortensen PB, Kyvik KO. Increased occurrence of schizophrenia and other psychiatric illnesses among twins. Br J Psychiatry. 1996;168:688-692.
40. Hultman CM, Sparen P, Takei N, Murray RM, Cnattingius S. Prenatal and perinatal risk factors for schizophrenia, affective psychosis, and reactive psychosis of early onset: case-control study. BMJ. 1999;318:421-426.
41. Sacker A, Done DJ, Crow TJ, Golding J. Antecedents of schizophrenia and affective illness. Obstetric complications. Br J Psychiatry. 1995;166:734-741.
42. Watkins ML, Scanlon KS, Mulinare J, Khoury MJ. Is maternal obesity a risk factor for anencephaly and spina bifida? Epidemiology. 1996;7:507-512.
43. Schaefer CA, Brown AS, Wyatt RJ, et al. Maternal prepregnant body mass and risk of schizophrenia in adult offspring. Schizophr Bull. 2000;26:275-286.
44. Cannon M, Jones PB, Murray RM. Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry. 2002;159:1080-1092.
45. Hao L, Ma J, Stampfer MJ, et al. Geographical, seasonal and gender differences in folate status among Chinese adults. J Nutr. 2003;133:3630-3635.
46. Pedersen CB, Mortensen PB. Evidence of a dose-response relationship between urbanicity during upbringing and schizophrenia risk. Arch Gen Psychiatry. 2001;58:1039-1046.
47. Lian ZH, Yang HY, Li Z. Neural tube defects in Beijing-Tianjin area of China. Urban-rural distribution and some other epidemiological characteristics. J Epidemiol Community Health. 1987;41:259-262.
48. Boyles AL, Hammock P, Speer MC. Candidate gene analysis in human neural tube defects. Am J Med Genet C Semin Med Genet. 2005;135:9-23.
49. Botto LD, Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol. 2000;151:862-877.
50. Brattstrom L, Wilcken DE, Ohrvik J, Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation. 1998;98:2520-2526.
51. Molloy AM, Daly S, Mills JL, et al. Thermolabile variant of 5,10-methylenetetrahydrofolate reductase associated with low red-cell folates: implications for folate intake recommendations. Lancet. 1997;349:1591-1593.
52. Lewis SJ, Zammit S, Gunnell D, Smith GD. A meta-analysis of the MTHFR C677T polymorphism and schizophrenia risk. Am J Med Genet B Neuropsychiatr Genet. 2005;135:2-4.
53. Muntjewerff JW, Kahn RS, Blom HJ, den Heijer M. Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis. Mol Psychiatry. 2006;11:143-149.
54. Mills JL, McPartlin JM, Kirke PN, et al. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet. 1995;345:149-151.
55. Waddington JL, Lane A, Larkin C, O'Callaghan E. The neurodevelopmental basis of schizophrenia: clinical clues from cerebro-craniofacial dysmorphogenesis, and the roots of a lifetime trajectory of disease. Biol Psychiatry. 1999;46:31-39.
56. Pippenger CE. Pharmacology of neural tube defects. Epilepsia. 2003;44(suppl 3):24-32.
57. Copp AJ, Brook FA, Estibeiro JP, Shum AS, Cockroft DL. The embryonic development of mammalian neural tube defects. Prog Neurobiol. 1990;35:363-403.